Sacubitril/Valsartan to Reduce Secondary Mitral Regurgitation

Angiotensin Receptor Neprilysin Inhibitor for Functional Mitral Regurgitation: The PRIME Study

(2019) Duk-Hyun Kang et al.   CIRCULATION

The reverse remodeling response to sacubitril/valsartan therapy in heart failure with reduced ejection fraction

(2018) Pieter Martens et al.   Cardiovascular Therapeutics

Effect of Cardiac Resynchronization Therapy on Exercise-Induced Pulmonary Hypertension and Right Ventricular-Arterial Coupling

(2018) Pieter Martens et al.   Circulation-Cardiovascular Imaging

Transcatheter Mitral-Valve Repair in Patients with Heart Failure

(2018) Gregg W. Stone et al.   NEW ENGLAND JOURNAL OF MEDICINE

Percutaneous Repair or Medical Treatment for Secondary Mitral Regurgitation

(2018) Jean-François Obadia et al.   NEW ENGLAND JOURNAL OF MEDICINE

Effect of Losartan on Mitral Valve Changes After Myocardial Infarction

(2017) Philipp E. Bartko et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Heart Failure with Myocardial Recovery - The Patient Whose Heart Failure Has Improved: What Next?

(2017) Petra Nijst et al.   PROGRESS IN CARDIOVASCULAR DISEASES

2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease

(2014) Rick A. Nishimura et al.   CIRCULATION

Defining “Severe” Secondary Mitral Regurgitation

(2014) Paul A. Grayburn et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure

(2014) John J.V. McMurray et al.   NEW ENGLAND JOURNAL OF MEDICINE

Mitral Leaflet Adaptation to Ventricular Remodeling

(2008) Miguel Chaput et al.   CIRCULATION